RobertA.BurgerMD
Obstetrics & Gynecology • Philadelphia, PAGynecologic Oncology
Director of Clinical Research and Gynecologic Oncology Fellowship Program, University of Pennsylvania
Dr. Burger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-662-3318Fax+1 215-349-5680
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1992 - 1996
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1988 - 1992
New York University School of MedicineClass of 1988
Harvard UniversityAB, Biochemistry, Cum Laude, 1980 - 1984
Certifications & Licensure
CA State Medical License 1991 - 2021
PA State Medical License 1991 - 2020
NV State Medical License 1998 - 2003
TX State Medical License 1997 - 2000
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- Join now to see all
Publications & Presentations
PubMed
- 1533 citationsPhase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncolo...Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke-Pearson
Journal of Clinical Oncology. 2003-09-01 - 58 citationsFertility sparing treatment for in situ and early invasive adenocarcinoma of the cervixMichael T. McHale, Thuan D. Le, Robert A. Burger, Mai Gu, Joanne Rutgers
Obstetrics and Gynecology. 2001-11-01 - 530 citationsInherited Mutations in Women With Ovarian CarcinomaBarbara M. Norquist, Maria I. Harrell, Mark F. Brady, Tom Walsh, Ming K. Lee
JAMA Oncology. 2016-04-01
Grant Support
- Angiogenesis Targeted Therapeutics Of Ovarian CancerNational Cancer Institute2001–2006
- Core--Clinical Research OfficeNational Cancer Institute2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
